Dr. Lisa Kiang, PhD
Claim this profileMore about Lisa Kiang, PhD
Clinical Trial Related
3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Lisa Kiang, PhD has experience with
- One Talk At A Time: General
- One Talk At A Time: Race
Breakdown of trials Lisa Kiang, PhD has run
Psychiatric and Behavioural Symptoms
Anxiety Disorders
Behavioral Symptoms
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lisa Kiang, PhD specialize in?
Lisa Kiang, PhD focuses on Psychiatric and Behavioural Symptoms and Anxiety Disorders. In particular, much of their work with Psychiatric and Behavioural Symptoms has involved treating patients, or patients who are undergoing treatment.
Is Lisa Kiang, PhD currently recruiting for clinical trials?
No, Lisa Kiang, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Lisa Kiang, PhD has studied deeply?
Yes, Lisa Kiang, PhD has studied treatments such as One Talk at a Time: General, One Talk at a Time: Race.
What is the best way to schedule an appointment with Lisa Kiang, PhD?
Apply for one of the trials that Lisa Kiang, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.